Reducing the economic burden in management of Guillain–Barre syndrome using modified plasmapheresis

Background: Guillain–Barre syndrome (GBS) is an autoimmune acute inflammatory demyelinating polyneuropathy affecting the peripheral nervous system treated with high-dose immunoglobulin, physical therapy, or plasmapheresis. Immunoglobulins are expensive and even plasmapheresis might not be affordable...

Full description

Bibliographic Details
Main Authors: Rekha Ramaswamy Iyer, Pragnesh Hasmukhlal Shah, Sher Sankar K Roy, Sushil Kumar Kundanlal Suri
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2016-01-01
Series:Asian Journal of Transfusion Science
Subjects:
Online Access:http://www.ajts.org/article.asp?issn=0973-6247;year=2016;volume=10;issue=2;spage=118;epage=121;aulast=Iyer